Rigel Pharmaceuticals (RIGL) P/E Ratio
P/E Ratio as of Jun 13, 2025: 9.90
Average9.80
Median9.72
Minimum9.14
Maximum10.54
9.90
Past Month+1.08 (12.24%)
The P/E ratio for Rigel Pharmaceuticals (RIGL) is 9.90 as of Jun 13, 2025. This represents a decrease of -74.96% compared to its 12-month average P/E ratio of 39.54. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Rigel Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Rigel Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Rigel Pharmaceuticals to industry peers.
Rigel Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Rigel Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Rigel Pharmaceuticals to industry peers.
Rigel Pharmaceuticals (RIGL) P/E Ratio Insights
See Rigel Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Rigel Pharmaceuticals (RIGL)
Order type
Buy in
Order amount
Est. shares
0 shares
Rigel Pharmaceuticals (RIGL) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $20.15 | 9.72 |
| May 1, 2025 | $18.72 | 19.26 |
| Apr 1, 2025 | $17.15 | 17.65 |
| Mar 3, 2025 | $22.37 | 23.02 |
| Feb 3, 2025 | $21.16 | 97.69 |
| Jan 2, 2025 | $17.32 | 79.96 |
Rigel Pharmaceuticals (RIGL) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 9.90 | -87.25% |
| 2024 | 77.65 | -852.42% |
| 2023 | -10.32 | +230.77% |
| 2022 | -3.12 | -86.84% |
| 2021 | -23.70 | +19.16% |
| 2020 | -19.89 | — |
FAQs About Rigel Pharmaceuticals (RIGL) P/E ratio
The latest P/E ratio of Rigel Pharmaceuticals (RIGL) is 9.90, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Rigel Pharmaceuticals’s last 12-month average P/E ratio is 39.54, compared to its current P/E ratio of 9.90. This reflects a decrease of -74.96%.
Rigel Pharmaceuticals’s current P/E ratio of 9.90 is lower than its last 12-month average P/E of 39.54. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Rigel Pharmaceuticals’s average P/E ratio over the last 3 years is 9.3. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Rigel Pharmaceuticals’s average P/E ratio over the last 5 years is -6.38. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.